The Current Ratio as of December 2024 (TTM) for Soligenix, Inc. (SNGX) is 2.28

According to Soligenix, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.28. This represents a change of 42.06% compared to the average of 1.60 of the last 4 quarters.

Soligenix, Inc. (SNGX) Historical Current Ratio (quarterly & annually)

How has SNGX Current Ratio performed in the past?

The mean historical Current Ratio of Soligenix, Inc. over the last ten years is 2.18. The current 2.28 Current Ratio has changed 10.35% with respect to the historical average. Over the past ten years (40 quarters), SNGX's Current Ratio was at its highest in in the March 2021 quarter at 7.27. The Current Ratio was at its lowest in in the June 2015 quarter at 0.56.

Soligenix, Inc. (SNGX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Soligenix, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Soligenix, Inc. (SNGX) Average Current Ratio

How has SNGX Current Ratio performed in the past?

The current Current Ratio of Soligenix, Inc. (SNGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Soligenix, Inc. (SNGX) Current Ratio vs. Peers

How is SNGX’s Current Ratio compared to its peers?

Soligenix, Inc.’s Current Ratio is less than Zura Bio Limited (10.36), greater than Apexigen, Inc. (1.29), less than Phio Pharmaceuticals Corp. (6.38), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Immix Biopharma, Inc. (3.47), less than Addex Therapeutics Ltd (4.59), greater than Aceragen, Inc. (0.83), greater than ERYTECH Pharma S.A. (0.38), less than Avenue Therapeutics, Inc. (2.70), less than Palisade Bio, Inc. (3.31), greater than ContraFect Corporation (0.53), less than Allarity Therapeutics, Inc. (2.75), greater than CNS Pharmaceuticals, Inc. (1.82), greater than Windtree Therapeutics, Inc. (0.27), less than Dermata Therapeutics, Inc. (3.44), less than Ensysce Biosciences, Inc. (3.24), greater than Panbela Therapeutics, Inc. (0.26), less than Baudax Bio, Inc. (0),

Build a custom stock screener for Soligenix, Inc. (SNGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Soligenix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Soligenix, Inc. (SNGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Soligenix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.